S. 4293 117th Congress
Pharmacy Benefit Manager Transparency Act of 2022
Latest action, Dec 14, 2022: Placed on Senate Legislative Calendar under General Orders. Calendar No. 647.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
8 cosponsors
Sponsored by Maria Cantwell (Democrat). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
1 D · 7 R
- Democrat
- Republican
- Independent
Referred to: Senate: Commerce, Science, and Transportation Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
AIDS HEALTHCARE FOUNDATION
PARRY, ROMANI, DECONCINI & SYMMS
3 reports
AMAC ACTION, INC.
SCHOENING STRATEGIES, LLC
3 reports
3 reports
AMERICAN PHARMACY COOPERATIVE, INC.
ARENTFOX SCHIFF LLP
3 reports
3 reports
BLUE CROSS BLUE SHIELD ASSOCIATION
AVENUE SOLUTIONS
3 reports
CIGNA CORPORATION
POLARIS GOVERNMENT RELATIONS, LLC
3 reports
3 reports
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC.
AVENUE SOLUTIONS
3 reports
3 reports
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS
HOOPER, LUNDY & BOOKMAN, P.C.
3 reports
3 reports
HEALTHCARE LEADERSHIP COUNCIL
AVENUE SOLUTIONS
3 reports
All 25 of 48 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| AIDS HEALTHCARE FOUNDATION | PARRY, ROMANI, DECONCINI & SYMMS | 3 | $180K | Q4 2022 | Q3 2022 | yes |
| AMAC ACTION, INC. | SCHOENING STRATEGIES, LLC | 3 | $0 | Q4 2022 | Q3 2022 | yes |
| AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | 3 | $8.6M | Q4 2022 | Q3 2022 | yes | |
| AMERICAN PHARMACISTS ASSOCIATION | 3 | $105K | Q4 2022 | Q3 2022 | yes | |
| AMERICAN PHARMACY COOPERATIVE, INC. | ARENTFOX SCHIFF LLP | 3 | $90K | Q4 2022 | Q3 2022 | yes |
| AMERICANS FOR TAX REFORM | 3 | $140K | Q4 2022 | Q3 2022 | yes | |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | 3 | $10.1M | Q4 2022 | Q3 2022 | yes | |
| BLUE CROSS BLUE SHIELD ASSOCIATION | AVENUE SOLUTIONS | 3 | $0 | Q4 2022 | Q3 2022 | yes |
| CIGNA CORPORATION | POLARIS GOVERNMENT RELATIONS, LLC | 3 | $270K | Q4 2022 | Q3 2022 | yes |
| COMMUNITY ONCOLOGY ALLIANCE | 3 | $553K | Q4 2022 | Q3 2022 | yes | |
| DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. | AVENUE SOLUTIONS | 3 | $210K | Q4 2022 | Q3 2022 | yes |
| ELEVANCE HEALTH, INC. | 3 | $4.4M | Q4 2022 | Q3 2022 | yes | |
| GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS | HOOPER, LUNDY & BOOKMAN, P.C. | 3 | $30K | Q4 2022 | Q3 2022 | yes |
| GSK (FKA GLAXOSMITHKLINE INC.) | 3 | $3.4M | Q4 2022 | Q3 2022 | yes | |
| HEALTHCARE LEADERSHIP COUNCIL | AVENUE SOLUTIONS | 3 | $0 | Q4 2022 | Q3 2022 | yes |
| LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) | AVENUE SOLUTIONS | 3 | $180K | Q4 2022 | Q3 2022 | yes |
| NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 3 | $1.2M | Q4 2022 | Q3 2022 | yes | |
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | 3 | $5.9M | Q4 2022 | Q3 2022 | yes | |
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) | RED+BLUE STRATEGIES | 3 | $210K | Q4 2022 | Q3 2022 | yes |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 3 | $20.2M | Q4 2022 | Q3 2022 | yes | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | CROSSROADS STRATEGIES, LLC | 3 | $0 | Q4 2022 | Q3 2022 | yes |
| PRIME THERAPEUTICS | GOVERNMENT COUNSEL, LLC | 3 | $0 | Q4 2022 | Q3 2022 | yes |
| SANOFI US SERVICES INC | 3 | $2.9M | Q4 2022 | Q3 2022 | yes | |
| SCAN HEALTH PLAN | AVENUE SOLUTIONS | 3 | $0 | Q4 2022 | Q3 2022 | yes |
| SNP ALLIANCE INC | AVENUE SOLUTIONS | 3 | $0 | Q4 2022 | Q3 2022 | yes |